Scientists across disease areas continue to propel their research, elucidating the immune response in diseases as varied as multiple sclerosis, metastatic melanoma, and peanut allergy.
Years: 2015
Honored Among Goldman Sachs’ 100 Most Intriguing Entrepreneurs
Chad and Harlan are honored by Goldman Sachs for their groundbreaking technology and the promise Adaptive can bring to the future of medicine.
A Giant Step Forward in Developing Clinical Diagnostics and Therapeutics
Adaptive develops new technology to map T cells to the antigens they target, providing the capability to see what diseases the immune system responds to and setting the stage for novel diagnostic tests. New technology to pair the chains of T-cell receptors (TCRs) helps identify which ones have the greatest therapeutic potential.